Vanderbilt Training Program in Academic Cancer Research

描述（由申请人提供）：抗癌进展包括我们提供高质量癌症治疗和支持临床试验研究的能力。然而，训练有素的肿瘤学家/血液学家缺乏能够全面研究临床相关问题的人才；成功设计和实施临床试验，以改善人类癌症的预防、检测和治疗；最重要的是，基础知识和新技术在实验室、诊所和社区之间的转化。培养成功的、独立的转化型癌症研究人员需要充足的保护时间、丰富的研究环境和组织良好的培训计划中的强有力的指导。范德比尔特-英格拉姆癌症中心是范德比尔特医疗中心的一个矩阵中心，由于其综合的癌症相关专业知识和资源，非常适合支持这样一个全面的培训计划。范德比尔特学术癌症研究培训计划的目标是培训和支持医学肿瘤学/血液学研究员，以确保他们在学术肿瘤学/血液学的各个方面取得成功，迎接新的挑战和机遇。候选人将从血液学和肿瘤学部门奖学金项目中招募。被录取的申请人将参加一个为期两年的综合培训计划，包括两个培训轨道：(1)临床研究者轨道将侧重于临床试验和相关研究的开发和实施；(2)医师科学家轨道将侧重于实验室研究。完成任何一个培训轨道的研究员将有资格获得ABIM医学肿瘤学和血液学的亚专业认证。在完成课程后，学员将能够成功地在协作团队环境中工作，通过假设驱动的研究开发和领导独立的研究项目，获得同行评审的资助支持，通过在同行评审的期刊上发表和发表他们的研究成果，并提供高质量的癌症治疗。为了确保成功，100%的项目教师都有癌症研究的同行评审支持，并积极开展临床和/或实验室基础的癌症研究，持续在最好的期刊上发表文章，表现出指导能力，并积极管理成功的研究项目。要求每年为两个培训职位提供支助。

DESCRIPTION (provided by applicant): Progress against cancer includes our ability to provide quality cancer care and support research within clinical trials. However, there is a significant shortage of well-trained oncologists/hematologists capable of comprehensive study of clinically-relevant problems; successful design and conduct of clinical trials to improve prevention, detection and treatment of human cancer; and most importantly, the translation of fundamental knowledge and new technologies between the laboratory, clinic, and community. The development of successful, independent translational cancer investigators requires adequate protected time and a strong mentorship in a rich research environment and well organized training program. The Vanderbilt-lngram Cancer Center, a matrix center within Vanderbilt Medical Center, is well-suited to support such a comprehensive training program due to its integrated cancer-related expertise and resources. The objective of the Vanderbilt Training Program in Academic Cancer Research is to train and support medical oncology/hematology fellows to ensure their success to meet new challenges and opportunities in all aspects of academic medical oncology/hematology. Candidates will be recruited from the Division of Hematology and Oncology Fellowship Program. Applicants accepted will participate in a comprehensive two-year training program consisting of two training tracks: (1) Clinical-Investigator Track will focus on the development and conduct of clinical trials and associated correlative studies (2) Physician-Scientist Track will focus on laboratory-based research. Fellows who complete either training track will be eligible for ABIM subspecialty certification in medical oncology and hematology. Upon completion of the program, trainees will be able to successfully function in a collaborative team environment, develop and lead independent research programs through hypothesis-driven research, obtain peer-reviewed grant support, communicate their research findings through presentations and publication in peer-reviewed journals, and provide high quality cancer care. To help ensure success, 100% of the program faculty have peer-reviewed support for cancer research and are actively conducting clinical and/or laboratory-based cancer research, consistently published in the best journals, have demonstrated mentorship abilities, and actively manage successful research programs. Support is being requested for two training positions per year.